Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) dropped 4.2% on Wednesday . The stock traded as low as $0.34 and last traded at $0.36. Approximately 357,431 shares traded hands during trading, an increase of 1,658% from the average daily volume of 20,327 shares. The stock had previously closed at $0.38.
ImmunoPrecise Antibodies Stock Up 5.2 %
The stock has a 50 day moving average of $0.42 and a 200 day moving average of $0.47.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Effectively Use the MarketBeat Ratings Screener
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is Insider Trading? What You Can Learn from Insider Trading
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What Are Trending Stocks? Trending Stocks Explained
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
